Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 166.27M P/E - EPS this Y 25.00% Ern Qtrly Grth -
Income -133.03M Forward P/E -1.42 EPS next Y 4.40% 50D Avg Chg -11.00%
Sales 14.61M PEG - EPS past 5Y - 200D Avg Chg -29.00%
Dividend N/A Price/Book 1.17 EPS next 5Y - 52W High Chg -68.00%
Recommedations 2.50 Quick Ratio 2.34 Shares Outstanding 118.11M 52W Low Chg 14.00%
Insider Own 1.91% ROA -46.71% Shares Float 115.44M Beta 0.49
Inst Own 33.36% ROE -201.94% Shares Shorted/Prior 6.63M/7.18M Price 1.87
Gross Margin - Profit Margin - Avg. Volume 882,153 Target Price 1.50
Oper. Margin -2,995.44% Earnings Date Nov 6 Volume 587,289 Change -1.58%
About Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Gritstone bio, Inc. News
11/07/24 Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
10/11/24 Gritstone Oncology Pursues Restructuring Through Chapter 11
10/10/24 Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
09/30/24 Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
08/16/24 Gritstone bio Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
08/13/24 Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
07/24/24 Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
07/10/24 Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/04/24 Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
05/11/24 Gritstone bio First Quarter 2024 Earnings: Misses Expectations
05/09/24 Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
05/02/24 Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024
04/30/24 Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024
04/29/24 Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
04/15/24 Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
04/08/24 Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
04/01/24 Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
04/01/24 Gritstone bio Announces Proposed Public Offering
04/01/24 Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
03/19/24 3 Speculative Stocks You Can Buy for $3 or Less
GRTS Chatroom

User Image laaarsas Posted - 17 hours ago

$GRTS Is there no way out of the bankruptcy? No financing possible? How did this happen? Seems like very bad management. I think they have good enough data for further clinical development. Could someone please summarise what happened here?

User Image caveat_emtor Posted - 19 hours ago

$GRTS What is the IP worth? They retained the Michel Shaked law firm which specializes in IP to produce a valuation report. That report was to be made available to the judge as well as to all the bidders. I thought the report would be public, but apparently it’s not. Anyway, that report would be a good basis for the bids. Does anyone know the status of this report?

User Image Keekster1 Posted - 1 day ago

$GRTS POLL QUESTIONS (we need to think positive…) 1. Who is the Stalking Horse? (If no stalking horse say why) 2. Stalking horse floor bid? 3. If bidding war ensues name 1-2 competing companies 4. Price per share for us commoners. 5. Other thoughts

User Image MRCPLS Posted - 1 day ago

$GRTS did anyone join the call?

User Image MRCPLS Posted - 1 day ago

$GRTS can my American folks please join the call now?

User Image ChrisLBoston Posted - 1 day ago

$GRTS Yes, shame on me for sitting and hoping for... a miracle I guess, but I've had the fortune of never owning a dog like this. So, is it as simple as selling and taking the loss on my taxes?

User Image BobMark Posted - 1 day ago

$GRTS Yup, the vultures come out. Pachulski Stang Ziehl & Jones LLP 10100 Santa Monica Blvd, Suite 1300 Los Angeles CA 90067 www.pszjlaw.com 7/2/2024 $100,000.00 Pachulski Stang Ziehl & Jones LLP 10101 Santa Monica Blvd, Suite 1300 Los Angeles CA 90067 www.pszjlaw.com 8/13/2024 $9,888.00 Pachulski Stang Ziehl & Jones LLP 10102 Santa Monica Blvd, Suite 1300 Los Angeles CA 90067 www.pszjlaw.com 8/29/2024 $8,646.50 Pachulski Stang Ziehl & Jones LLP 10103 Santa Monica Blvd, Suite 1300 Los Angeles CA 90067 www.pszjlaw.com 9/12/2024 $750,000.00 Pachulski Stang Ziehl & Jones LLP 10104 Santa Monica Blvd, Suite 1300 Los Angeles CA 90067 www.pszjlaw.com 10/3/2024 $750,000.00 PWC US Business Advisory LLP P.O. Box 200988 Dallas TX 75320-0988 www.pwc.com 9/10/2024 $200,000.00 PWC US Business Advisory LLP P.O. Box 200988 Dallas TX 75320-0988 www.pwc.com 9/12/2024 $200,000.00 PWC US Business Advisory LLP P.O. Box 200988 Dallas TX 75320-0988

User Image BobMark Posted - 1 day ago

$GRTS One has to love that Allen was not afraid to spend money in buckets. Gritstone Biopharmaceuticals UK LTD.

User Image Bobby_XiDada Posted - 2 days ago

$GRTS any news on stalking horse?

User Image Myturn Posted - 2 days ago

$GRTS It seems that a shareholder is advocating for the rights of himself and others. Should we, as shareholders, support him to represent our collective voice? Personally, he could have my full support, representing my shares

User Image Keekster1 Posted - 2 days ago

$GRTS the Stalking Horse can only make an offer to BO the company…is that correct? Not make an offer to sponsor/partner?

User Image ReturnOfEsquire Posted - 2 days ago

$GRTS Warning here is swinging companies with bad fundamentals can get you stuck permanently. I've learned and now only swing companies with cash and catalysts so if I get stuck it's temporary.

User Image MRCPLS Posted - 2 days ago

$GRTS Didn't we already listen to this court hearing. Why is this redacted?

User Image exdoc Posted - 2 days ago

$GRTS so if they manage to sell the assets for more than the liabilities, will shareholders receive a liquidation dividend as they wind up the company? Or how will it work? PS what a f%$#@$ing disaster!

User Image Olininvestr Posted - 2 days ago

$GRTS …hmmm 🤔 Moderna — Shares popped 2.4% after HSBC upgraded Moderna to buy from hold, saying the pharmaceutical company’s shift to oncology from respiratory vaccines could unlock future

User Image Bobby_XiDada Posted - 3 days ago

$GRTS she should have some shame

User Image nedz13 Posted - 3 days ago

$GRTS Probably also warrants are ahead of shareholders in the line for money, what do you think guys?

User Image RealErnFranklin Posted - 3 days ago

$GRTS Bullrun isnt good at things. That sucks. Sorry, guess u better be a dope instead to get your attention. $zone 🔥

User Image MRCPLS Posted - 3 days ago

$GRTS I guess they're hopeful that they'll still exist by February 25: https://mrna-analytical-development.com/program/day-two/

User Image MRCPLS Posted - 3 days ago

$GRTS what are we missing? Why is market cap at 2.9mn? Will we not reach even a 100mn bid offer?

User Image MRCPLSN Posted - 4 days ago

$GRTS If big pharma was really interested in samRNA, Gritstone would be the the one to aqcuire.

User Image nedz13 Posted - 4 days ago

$GRTS Buyout is out of question until litigations are decided. Unless CVR would be granted on this case.

User Image BobMark Posted - 4 days ago

$GRTS BP is all about ling term. She said Gilead is “prioritizing resources as we prepare for six potential new launches by the end of 2030.”

User Image laaarsas Posted - 5 days ago

$GRTS Some care to explain why the stock price has been absolutely obliterated recently? What are the main issues? From what little I can read, there is a decent chance that GRANITE could have a clinically meaningful effect. Would love to hear what you guys have to say! /L

User Image MRCPLS Posted - 6 days ago

$GRTS there's simply no reason to pay anything to shareholders, is there? I mean, it's not the highest bidder that will win, but the "best", the one that promises to take forward the science and employees

User Image Cashcowtipper Posted - 6 days ago

$GRTS down 8k 🤮

User Image MRCPLS Posted - 6 days ago

$GRTS Monday November 25... Maybe they'll push it to earlier date to make sure they comply with 14 days period... Maybe 21st then?

User Image MRCPLS Posted - 6 days ago

$GRTS Gritstone still listed on Barda Project Next Gen, still listed on Gilead as oke of their opt-ins...

User Image Bobby_XiDada Posted - 6 days ago

$GRTS surely gonna fuck bids even more

User Image MRCPLS Posted - 6 days ago

$GRTS why the f#ck am I still optimistic?? And what's gonna happen to HIV with Gilead?

Analyst Ratings
HC Wainwright & Co. Neutral Oct 1, 24
JMP Securities Market Perform Oct 1, 24
HC Wainwright & Co. Buy Aug 15, 24
JMP Securities Market Outperform Aug 5, 24
HC Wainwright & Co. Buy Aug 5, 24
JMP Securities Market Outperform Jun 14, 24
B. Riley Securities Buy May 24, 24
HC Wainwright & Co. Buy May 13, 24
JMP Securities Market Outperform Apr 2, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Economides Vassiliki See Remarks See Remarks May 23 Buy 1.9024 12,000 22,829 214,058 05/24/23